CDSL Share Price

Mumbai News, 26 February 2026: Today, Thursday, shares of Central Depository Services (India) Limited (CDSL Share Price) have seen a slight to moderate drop since morning. Around 1:30 pm, CDSL shares were trading between ₹1,295 and ₹1,300 on NSE. The previous day’s (25 February) closing price was ₹1,326.80, so today’s drop is around 2.2 to 2.5 percent. A similar trend was seen on BSE, where the price was around ₹1,298 to ₹1,302.

Today’s live trading updates (26 February 2026, until 1 PM):

  • Opening price: ₹1,324 (NSE)
  • Day high: ₹1,324
  • Day low: ₹1,287 to ₹1,298
  • Previous close: ₹1,326.80
  • Volume: around 8 to 12 lakh shares (mainly NSE trades)
  • Market capitalization: around ₹27,000 to ₹27,150 crore
  • 52-week high: ₹1,828.90 (June 2025)
  • 52-week low: ₹1,047.45

Today’s trading started with mixed feelings. By 9:30 in the morning, the price had dropped to ₹1,304.60 (down 1.68%). There was some stability by noon, but overall negative market signals and profit booking kept the pressure on. Trading on BSE was low, with most buying and selling happening on NSE.

CDSL Share Price - Nifty Share Price

A brief about the company

CDSL is one of the two major depositories in India (the other is NSDL). It provides demat account management, electronic shareholding and settlement services. Currently, the company has over 16.5 crore investor accounts. With growth in IPOs, mutual funds and the capital market, CDSL is expected to see good long-term growth. In Q3 FY26 (December 2025 quarter), the company performed well – total revenue increased by 12% to ₹334 crore and net profit was recorded at ₹133 crore.

What do Dalal Street analysts and top brokers say about CDSL Share Price target?

Major brokerages and analysts on Dalal Street are positive on CDSL in the long term but maintain a neutral to hold view at current prices. According to the latest consensus from Trendlyne (up to February 2026, based on 4 reports from 2 analysts):

  • Average target price: ₹1,455
  • Upside potential: 9.66% to 12% from current prices (based on 1320-1300)
  • Rating breakdown: 1 Hold, 3 Neutral

Top brokerage recommendations (latest reports):

  1. Motilal Oswal (2 February 2026): Neutral, target ₹1,410. “Quarter weak, but market momentum is improving.”
  2. ICICI Securities (November 2025): Hold, target ₹1,500. ‘Earnings improving on track, market momentum is good.’
  3. Alphaspread (Dalal Street Consensus): 1-year average target ₹1,484.61, high ₹1,743, low ₹1,313.

Some brokers (like Choice Equity) recommend buying at the current level and see a chance of it reaching ₹1,650-1,700 in the long term. Reasons: continuous growth in demat accounts, regulatory digitization, IPO pipeline and growth of the mutual fund industry. However, in the short term there is market volatility, a high P/E ratio (currently around 57) and the risk of profit booking.

Technical analysis and market context

  • P/E ratio: 56.88 to 57
  • P/B ratio: 14.43 to 15.91
  • 50-day moving average: ₹1,393.87 (current price below this)
  • 200-day moving average: ₹1,540.60

Today the overall market (Nifty and Sensex) was trading mixed to negative. There was also pressure in the capital market sector. The fall in stable stocks like CDSL is mainly due to profit booking and high valuation.

Expert’s opinion

Short-term traders should keep an eye on the support level of ₹1,280-1,290. If it breaks down, a fall to ₹1,250 is possible. For long-term investors, the current levels could be attractive as the capital market’s structural growth trend continues. However, considering market volatility, it is important to set stop-losses and diversify the portfolio.

CDSL is a company with high growth potential, but due to the current high valuation, it’s wise to be cautious. For more updates, check the NSE/BSE website or a reliable broker platform.

Disclaimer:
NiftySharePrice.com stock market news is based on publicly available authentic data sources like NSE – BSE and SEBI-authorized brokers & analysts only. Investing in the stock market involves risk. So, do your own research and consult your authorized advisors before investing.